BioSpace News Archive

Business

Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results

Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced its financial results for the fiscal year ended December 31, 2020.

April 30, 2021
·
15 min read
Business

MEI Pharma Announces the Retirement of Chief Medical Officer Robert Mass and Promotion of Richard Ghalie to Chief Medical Officer

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI”), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the retirement of Robert Mass, M.D., MEI’s chief medical officer.

April 30, 2021
·
5 min read
Deals

Scientific Industries Announces Acquisition of aquila biolabs to Advance Platform for Digitally Simplified Bioprocessing

Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of optical sensors for non-invasive, real-time monitoring of cell culture systems through its subsidiary Scientific Bioprocessing, Inc. (“SBI”), today announced its acquisition of aquila biolabs GmbH,

April 30, 2021
·
5 min read
Therapeutic Solutions International Comes to Agreement with FDA on Clinical Trial Design for First Stem Cell Clinical Trial in Chronic Traumatic Encephalopathy (CTE) Patients

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today receipt of a written communication from the Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application, which was granted number 27377.

April 30, 2021
·
2 min read
Pharm Country

New Study Confirms the Stability and Potency of a Novel Formulation of Liquid Levothyroxine

A new study of the potency and stability of liquid formulations of levothyroxine is being presented at the Pediatric Endocrine Society (PES) Annual Meeting.

April 30, 2021
·
6 min read
Pharm Country

AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced expanded access to its accelerated solutions platform, spanning research & development to manufacturing for orphan and rare disease products.

April 30, 2021
·
3 min read
Business

Scientific Industries Announces Appointment of Dr. Jürgen Schumacher to the Board of Directors

Scientific Industries, Inc. (OTCQB: SCND) today announced the appointment of Dr. Jürgen Schumacher to the Company’s Board of Directors

April 30, 2021
·
3 min read
Bio NC

BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the European Commission (EC) has approved oral, once-daily ORLADEYO™ (berotralstat) for the prevention of recurrent hereditary angioedema (HAE) attacks in HAE patients 12 years and older.

April 30, 2021
·
7 min read
Business

Polydex Pharmaceuticals Issues Year End Financial Results

Polydex Pharmaceuticals Limited (Pink Sheets: POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2021

April 30, 2021
·
2 min read
FDA

FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose

The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

April 30, 2021
·
3 min read